BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35166004)

  • 1. UK guideline for the use of HIV post-exposure prophylaxis 2021.
    Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
    HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015.
    Cresswell F; Waters L; Briggs E; Fox J; Harbottle J; Hawkins D; Murchie M; Radcliffe K; Rafferty P; Rodger A; Fisher M
    Int J STD AIDS; 2016 Aug; 27(9):713-38. PubMed ID: 27095790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
    Beekmann SE; Henderson DK
    Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda.
    Ayieko J; Petersen ML; Kabami J; Mwangwa F; Opel F; Nyabuti M; Charlebois ED; Peng J; Koss CA; Balzer LB; Chamie G; Bukusi EA; Kamya MR; Havlir DV
    J Int AIDS Soc; 2021 Jun; 24(6):e25670. PubMed ID: 34152067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011).
    Benn P; Fisher M; Kulasegaram R; ;
    Int J STD AIDS; 2011 Dec; 22(12):695-708. PubMed ID: 22174049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does dropping day 5 PEP follow-up affect outcomes? An audit of HIV post-exposure prophylaxis at a central London sexual health clinic.
    O'Keeffe C; Nwokolo N; McOwan A; Whitlock G
    Int J STD AIDS; 2015 Jul; 26(8):590-2. PubMed ID: 25122580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the 2011 UK post-exposure prophylaxis for HIV following sexual exposure guidelines: a regional retrospective audit.
    Bennett A; Wainwright E; Lord E; Oduru M; Chen F; Desmond N; Sherrard J; Duncan S
    Int J STD AIDS; 2015 Sep; 26(10):746-8. PubMed ID: 25332226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
    Young TN; Arens FJ; Kennedy GE; Laurie JW; Rutherford Gw
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002835. PubMed ID: 17253483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure.
    Fisher M; Benn P; Evans B; Pozniak A; Jones M; Maclean S; Davidson O; Summerside J; Hawkins D;
    Int J STD AIDS; 2006 Feb; 17(2):81-92. PubMed ID: 16464267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    Scholten M; Suárez I; Platten M; Kümmerle T; Jung N; Wyen C; Ernst A; Horn C; Burst V; Suárez V; Rybniker J; Fätkenheuer G; Lehmann C
    HIV Med; 2018 Oct; 19(9):645-653. PubMed ID: 29993176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postexposure prophylaxis against human immunodeficiency virus.
    Tolle MA; Schwarzwald HL
    Am Fam Physician; 2010 Jul; 82(2):161-6. PubMed ID: 20642270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
    Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pre-exposure and post-exposure prophylaxes prevention programme on HIV burden and services in a low-resource setting: a simulation modelling approach.
    Adeoti AO; Demir E; Adeyemi S; Yakutcan U; Kengne AP; Kayode G; Aliyu A; Idika N; Isichei C
    Pan Afr Med J; 2021; 40():163. PubMed ID: 34970405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus.
    Havens PL;
    Pediatrics; 2003 Jun; 111(6 Pt 1):1475-89. PubMed ID: 12777574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.